Newbridge Financial Services Group, Inc. Chemomab Therapeutics Ltd. Transaction History

Newbridge Financial Services Group, Inc.

  • $633 Million
  • Q4 2025

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022
BUY
$3.53 - $7.2 $3,883 - $7,920
1,100 New
1,100 $5,000

Others Institutions Holding CMMB

# of Institutions
2
Shares Held
2.76K
Call Options Held
0
Put Options Held
0
View Full List

About Chemomab Therapeutics Ltd.

CMMB Quotes by TradingView
  • Ticker CMMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,431,700
  • Market Cap $30.4M
  • Description
  • Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...
More about CMMB
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email